Researchers at the University of California, Irvine (UCI) are utilizing microgravity environments aboard the International Space Station (ISS) to engineer cartilage tissue, according to a report from Parse Biosciences. The study, led by Dr. Wendy Brown and Dr. Kyriacos Athanasiou of the DELTAi Lab, employs single-cell RNA sequencing to analyze how chondrocytes—cartilage cells—rejuvenate and self-assemble without the constraints of Earth’s gravity. The project, funded by the National Science Foundation, aims to address the global need for effective cartilage repair implants.
Why is microgravity essential for cartilage engineering?
Gravity often hinders the formation of high-quality cartilage tissue in ground-based laboratories. Research suggests that tissues engineered in orbit can come closer to the real thing than tissues engineered on the ground. By removing gravitational forces, the UCI team allows cells to self-assemble into neocartilage without the need for synthetic scaffolds. According to the research team, this process involves rejuvenating highly expanded chondrocytes to restore their gene expression and the cells’ ability to produce cartilage before maturing them under mechanical tension in flight-certified hardware provided by BioServe Space Technologies.
How are researchers tracking cell development in orbit?
The study relies on Evercode Cell Fixation technology to preserve biological samples at various stages of development. Dr. Rachel Nordberg, who is leading the study to examine the rejuvenation of these cells, noted that the platform’s ability to handle the “unpredictability of spaceflight operations” and its compatibility with the Yucatan minipig model are critical to the project’s success. Samples are collected from the initial hours of differentiation through nearly 30 days of culture, then returned to Earth for single cell RNA sequencing.
The researchers are using the Yucatan minipig as a specialized animal model. Because the Evercode platform is species-agnostic, it allows the team to collect data across multiple timepoints.
What are the potential clinical implications?
Cartilage injuries currently affect hundreds of millions of people worldwide, often leading to chronic pain and long-term disability. Current treatment options frequently require harvesting tissue from donor sites, which can cause secondary harm to the patient. By perfecting the ability to grow functional, lab-engineered cartilage, researchers hope to create implants that regenerate damaged areas without relying on donor tissue. According to Charlie Roco, Co-founder and Chief Technology Officer at Parse Biosciences, this work could “fundamentally change how we think about tissue repair.”
Frequently Asked Questions
Why use the Yucatan minipig model?
The Yucatan minipig is a specialized animal model used in this study.
How are the samples returned to Earth?
The samples are processed in flight-certified hardware developed by BioServe Space Technologies. They are preserved using Evercode Cell Fixation while on the ISS, which ensures the cellular data remains stable during the return journey to Earth for single cell RNA sequencing.
What is the role of Parse Biosciences in this project?
Parse Biosciences provides the Evercode Cell Fixation technology that allows researchers to preserve and analyze the gene expression of the engineered cartilage cells.
When researching space-based biological manufacturing, look for studies that utilize “species-agnostic” platforms; these tools are increasingly vital for cross-disciplinary research.
Are you interested in the future of regenerative medicine? Subscribe to our newsletter for the latest updates on space-based biotechnology and tissue engineering breakthroughs.
Keep reading